Biotechnology News This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Singapore's First Home-Grown Influenza Vaccine In Phase 1 Clinical Trial
The vaccine based on Cytos' Virus-Like Particle technology may open the door to accelerated production of influenza vaccines in Singapore Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 21, 2013 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news

U.S. gov't anthrax adviser was on drugmaker's board
After former Navy secretary urged gov't to stockpile anti-anthrax drug, his biotech firm won $334M in federal contracts beginning in 2006 (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 20, 2013 Category: Consumer Health News Source Type: news

Germ-fighting vaccine system makes great strides in delivery
(American Association of Pharmaceutical Scientists) A novel vaccine study from South Dakota State University will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' National Biotechnology Conference. The meeting takes place Monday, May 20 - Wednesday, May 22 at the Sheraton San Diego Hotel and Marina. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 20, 2013 Category: Global & Universal Source Type: news

Faulty Energy Production In Brain Cells Leads To Learning Disabilities
Dysfunctional mitochondria in brain cells can result in learning disabilities, according to a new study in Molecular Cell. The association between dysfunctional mitochondria and Parkinson's disease has been known, but this new study, led by neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven, has revealed that it is also present in other disorders of the brain. Patrik Verstreken (VIB / KU Leuven) said: "This discovery shows that energy production in brain cells is the basis of various brain disorders... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2013 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

Lack of CoQ10 in blood causes serious illness: Study
A recent study at Harvard Medical School, recorded April 22, 2013 in the National Center for Biotechnology Information (NCBI), provided an association with low blood level CoQ10 to critical illness. There were 32 critically ill patients compared to 18 healthy control... (Source: NaturalNews.com)
Source: NaturalNews.com - May 17, 2013 Category: Consumer Health Advice Source Type: news

Jennerex Announces Science Translational Medicine Publication
Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced the publication of data demonstrating the ability of its lead product-candidate, Pexa-Vec (JX-594, pexastimogene devacirepvec) to induce functional anti-cancer immunity, both in patients with diverse solid tumor types and in animal models.05/16/2013 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - May 16, 2013 Category: Cancer & Oncology Source Type: news

Engineered Biomaterial Could Eliminate The Body's Negative Reaction To Medical Implants
It's a familiar scenario - a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system. Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response. Their findings were published online this week in the journal Nature Biotechnology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 16, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news

A*STAR and Cytos bring Singapore's first influenza vaccine to clinical testing
(Agency for Science, Technology and Research (A*STAR), Singapore) Singapore's Agency for Science, Technology and Research and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle technology. In this first Phase 1 clinical trial, the safety and immunogenicity of this novel vaccine candidate and its potential to protect against H1N1 influenza infection will be evaluated. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 16, 2013 Category: Global & Universal Source Type: news

Patient-Specific Human Embryonic Stem Cells Created by Cloning
From Nature magazine [More] (Source: Scientific American Topic - Biotechnology)
Source: Scientific American Topic - Biotechnology - May 15, 2013 Category: Biotechnology Tags: Health,Technology,Society & Policy,Medical Technology,Biotechnology,Biotechnology,Ethics,Health,More Science Source Type: news

M-Files QMS Deployed by MolecularMD for Laboratory Documentation and...
Provider of Diagnostics Products and Services to Pharmaceutical and Biotech Companies Implements M-Files QMS(PRWeb May 14, 2013)Read the full story at http://www.prweb.com/releases/2013/5/prweb10728079.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 15, 2013 Category: Pharmaceuticals Source Type: news

Accelrys Externalized Collaboration Suite Moves Research Networks To The Cloud
Bio-IT World, Boston – Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of the Accelrys Externalized Collaboration Suite, a software solution designed specifically to address the needs of life sciences organizations engaged in externalized network research. The suite is the only offering currently available that addresses the full range of externalization needs from technology transfer through networked collaboration to scientific informatics across all research data including experiments, chemical structures, assays and other test resu...
Source: Pharmaceutical Online News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Therapure Biopharma Receives BIOTECanada Gold Leaf Award
Therapure Biopharma is pleased to announce today that it has been awarded the Gold Leaf Award for Emerging Company of the Year by BIOTECanada in the Health Biotech Category for 2012. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 15, 2013 Category: Pharmaceuticals Source Type: news

Exclusive Q&A With a Woman Pioneer in Biotech
Innovation thrives when different people come together. Diversity stimulates imagination and new ideas. However, 35 years ago, there were very few women in life sciences and venture capital. Nola Masterson was a pioneer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2013 Category: Pharmaceuticals Authors: Victor W. Hwang Source Type: news

Development of rotavirus a significant victory: US
US today congratulated India for developing an indigenous rotavirus vaccine for prevention of diarrhoea, terming it a significant victory. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Take steps to stop use of adulterated drugs in India: Rajinder Sachar
Former chief justice of Delhi High Court Rajinder Sachar has demanded that Indian authorities take steps to stop their use in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Patheon to Feature its Complex Formulation Technologies Expertise
Patheon personnel will be available to meet at the CPhI/ICSE Japan conference in Tokyo from April 24-26, 2013 to discuss how Patheon can actively support pharmaceutical and biotech companies achieve their key development and manufacturing goals (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Phase III Clinical Trial Results For Rotavirus Vaccine Developed In India
The Government of India's Department of Biotechnology (DBT) and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented at the International Symposium on Rotavirus Vaccines for India -The Evidence and the Promise, showed ROTAVAC® to have an excellent safety and efficacy profile. The clinical study demonstrates for the first time that the India-developed rotavirus vaccine ROTAVAC® is efficacious in preventing severe rotavirus diarrhoea in low-resource settings in India... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 15, 2013 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

Ranbaxy may take a $1-billion hit in US
The damage to India’s largest drug major, Ranbaxy , translates well beyond the $500 million -which was confirmed as total penalty on May 13. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

FDA's Role in Regulating Safety of GE Foods
GMOs, genetically modified organisms, biotech foods, or genetically engineered foods - whatever name they're called - seem to be a captivating topic. Learn more about them and how they are regulated in this FDA Consumer Update. (Source: FDA Consumer Updates)
Source: FDA Consumer Updates - May 14, 2013 Category: Consumer Health Advice Source Type: news

Australia Welcomes Custom Mammalian-Based Biopharmaceutical Manufacturing
DSM Pharmaceutical Products announced at Bio International 2013 that its’ new cGMP custom biopharmaceutical manufacturing ‘biologics plant of the future’ was set to open in June 2013 in Brisbane, Australia. The facility will be adjacent to the Translational Research Institute of Queensland, Australia’s comprehensive medical research and biopharmaceutical facility located on the Princess Alexandra Hospital campus. The state-of-the-art commercial and development facility was built with the cooperation of the Queensland and Commonwealth Governments of Australia. Australia currently has a vibrant biote...
Source: Pharmaceutical Online News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Results of the ROTAVAC Rotavirus Vaccine Study in India
We congratulate the Program for Appropriate Technology in Health (PATH), Bharat Biotech International, Ltd., and the scientists, government and people of India on the important results from the ROTAVAC rotavirus vaccine study. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 14, 2013 Category: American Health Source Type: news

Scientists unveils first Made in India rotavirus vaccine
Scientists today unveiled the first completely indigenous and affordable vaccine to prevent severe rotavirus diarrhoea, which kills more than one lakh children under the age of five in India very year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Piramal gets USDFA nod for anti-diabetic molecule
Piramal Enterprises today said it has received approval from the USFDA for its investigational new drug, P11187, that aims to target diabetes. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

MSD India to invest $10 mn to cut maternal mortality
MSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar Pradesh. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Engineered biomaterial could improve success of medical implants
(University of Washington) Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response. Their findings were published online this week in the journal Nature Biotechnology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2013 Category: Global & Universal Source Type: news

Rotavirus vaccine developed in India demonstrates strong efficacy
(PATH) The Government of India's Department of Biotechnology and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented today at the International Symposium on Rotavirus Vaccines for India -- The Evidence and the Promise, showed ROTAVAC® to have an excellent safety and efficacy profile. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2013 Category: Global & Universal Source Type: news

Lobby fears norms violation in Cipla's biosimilar drug
A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2013 Category: Pharmaceuticals Source Type: news

Indiana Farmer Vernon Bowman Loses Lawsuit to Monsanto
Back in February the Supreme Court heard arguments from farmer Vernon Bowman on why he didn't need to pay royalties to Monsanto for growing their patented GMO soybeans that have been genetically modified to be resistant to the pesticide in Round-Up. Today, Mr. Bowman lost his case when the Court unanimously ruled against him. He owes Monsanto $84,000 in royalties....Read Full Post (Source: About.com Biotech Biomedical)
Source: About.com Biotech Biomedical - May 13, 2013 Category: Biotechnology Source Type: news

Goldman Sachs to invest Rs 110 cr in BPL Med
Medical device company BPL Medical Technologies has secured an equity commitment of Rs 110 crore ($ 20 million) from Goldman Sachs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2013 Category: Pharmaceuticals Source Type: news

Domestic pharma growth rebounds for the month of April
There was an improvement of growth in case of the anti-infectives segment, being the largest category in the Indian pharmaceutical market constituting nearly 18% of the industry revenues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2013 Category: Pharmaceuticals Source Type: news

A Patient's Right To Control Genomic Health Information
Doctors should not have the right or responsibility to force-feed their patients with genomic information about their future health risks, according to bioethicists writing in Trends in Biotechnology, a Cell Press publication. They write in response to controversial recommendations from the American College of Medical Genetics and Genomics (ACMG) on the reporting of incidental findings in clinical genome sequencing... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 13, 2013 Category: Consumer Health News Tags: Genetics Source Type: news

Cloning Human Embryos
Last week researchers at Oregon Health and Science announced they had made human embryo clones using skin cells. The technique was similar to the one used to clone Dolly, the sheep, almost 20 years ago. Why has it taken so long to clone humans? Are we that different than sheep?...Read Full Post (Source: About.com Biotech Biomedical)
Source: About.com Biotech Biomedical - May 13, 2013 Category: Biotechnology Source Type: news

Bill would regulate 'biosimilar' drugs
As some firms want to make and sell drugs similar to biological medicines made by the likes of Amgen and Genentech, a measure aims to regulate their use.SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. (Source: L.A. Times - Health)
Source: L.A. Times - Health - May 12, 2013 Category: Consumer Health News Source Type: news

Use services of nurses for better healthcare: Prez
Prez Pranab Mukherjee today suggested effective utilisation of the services of nurses to help improve health services in rural areas. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 12, 2013 Category: Pharmaceuticals Source Type: news

Lupin expects to launch 20-25 products in US/yr
Drug major Lupin Ltd expects to launch 20-25 products in the American market every year in the next couple of years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 12, 2013 Category: Pharmaceuticals Source Type: news

Super-specialty mental health facility in Kolkata
Addlife Caring Minds, the first super-specialty mental health facility offering a host of services under one roof, was unveiled today. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 11, 2013 Category: Pharmaceuticals Source Type: news

Birds of Burden: 7 Ways Humans Harness Avian Abilities [Slide Show]
Many of the 10,000 or so bird species on the planet are pretty, melodic or tasty. But birds are much more than that. Over the centuries, humankind has come up with some distinctive and surprising ways to take advantage of the unique abilities of our feathered friends. At various points in the history of civilizations, birds have served as hunters, guides and messengers. And we haven’t run out of new things for them to do. Farmers have employed raptors to strike terror into the hearts of crop-destroying birds, such as starlings and seagulls, scattering them back into the wild. With the proper training, birds might one...
Source: Scientific American Topic - Biotechnology - May 11, 2013 Category: Biotechnology Tags: More Science,Environment,Health,History of Science,Technology,Biotechnology,Everyday Science,Ecology,Biotechnology,Biology,Society & Policy Source Type: news

Bio Architecture Lab Shifts Strategy To Become Contract Research Organization
Bio Architecture Lab (BAL), a premier biotechnology company with a development focus in renewable chemicals and fuels, will be leveraging its deep expertise in biotechnology research and development to offer synthetic biology and technical services to industrial and specialty manufacturers worldwide as a Contract Research Organization (CRO). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - May 11, 2013 Category: Pharmaceuticals Source Type: news

Produce Industry s Food Safety Push Takes Toll on the Environment
Clean greens are healthy greens. [More] (Source: Scientific American Topic - Biotechnology)
Source: Scientific American Topic - Biotechnology - May 10, 2013 Category: Biotechnology Tags: Energy & Sustainability,Health,Society Policy,More Science,Infectious Diseases,Climate,Ecology,Biotechnology,Biotechnology,Ethics,Environment,Energy Source Type: news

Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%
Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 10, 2013 Category: Pharmaceuticals Source Type: news

VLCC looks at tie-up with Gujarat, Maharashtra Governments
VLCC Healthcare today said it was looking for arrangement with Governments of Gujarat and Maharashtra to facilitate admission of poor students in job- oriented courses. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 10, 2013 Category: Pharmaceuticals Source Type: news

Sikkim to go slow on multimillion cervical cancer vaccine project
The state has decided to go slow on it putting the already troubled multimillion vaccine deal further deep under uncertainty. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 10, 2013 Category: Pharmaceuticals Source Type: news

CCI orders probe against Cipla, 3 others for anti-competitive acts
Macleods Pharmaceuticals, FDC, Cipla, Himachal Pradesh Society of Chemist & Druggist Alliance and its president will be probed by DG Investigation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 9, 2013 Category: Pharmaceuticals Source Type: news

Sunlight could help you fight Blood Pressure
Human beings are the products of evolution, and it is unlikely — if not preposterous — that nature made us to stay indoors. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 9, 2013 Category: Pharmaceuticals Source Type: news

Dendreon's cancer vaccine sales drop as competition heats up
(Reuters) - Sales of Dendreon Corp's prostate cancer vaccine Provenge declined in the first quarter despite efforts by the biotechnology drugs maker to shore up flagging volumes. (Source: Reuters: Health)
Source: Reuters: Health - May 9, 2013 Category: Consumer Health News Tags: healthNews Source Type: news